For your biotechnology conference
Founded in 2004 to bridge research, development and industry in the production of affordable biologics.
World Biopharm Forum was formed in 2004 because our founder, Dr Subramanian, recognised there was not enough interaction between research and development and its effective implementation in industries, to advance the production of affordable biologics.
Since its inception, Dr Subramanian has created annual conferences aimed at increasing productivity of drugs and maintaining quality in keeping with the regulatory authorities. All conference speakers are sourced internationally and are experienced in their domain, many from the USA, Europe and UK, working in academia and industry.
Today, our conferences are attended by leading biopharmaceutical industries, academic researchers and developers in industry. Historically, our largest conference in terms of attendance was held in Gothenburg, Sweden. Dr Subramanian remains a regular contributor to biotechnology through the annual publication of books.
History shows that in biopharma uptake of innovation is metered, but if the invention has checked all the user need boxes its acceptance has an inflection point that resembles a hockey stick.
As current biological product pipelines become more diverse, product demands are varied while there is an increased pressure to keep cost of development and production down.
ABER continue to develop key solutions for bioprocessing and look forward to showcasing some of these developments with you over the course of World Biopharm Forum 2022.
When designing strategies to reduce time and cost in biologics development and manufacturing, one must think about bioprocess intensification.
Contact us for more information about the conference, sponsorship or tickets.
